The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant (Q37869391)

24 August 2017

1 reference

title

The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant (English)

1 reference

24 August 2017

Irvin M Modlin

1

1 reference

24 August 2017

Steven F Moss

2

1 reference

24 August 2017

Bjorn I Gustafsson

3

1 reference

24 August 2017

Ben Lawrence

4

1 reference

24 August 2017

Simon Schimmack

5

1 reference

24 August 2017

Mark Kidd

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

27 April 2011

1 reference

Langenbeck's Archives of Surgery

24 August 2017

1 reference

24 August 2017

396

1 reference

24 August 2017

1145-1156

1 reference

24 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s00423-011-0794-7

24 August 2017

0 references

cites work

Gastroenteropancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

The epidemiology of gastroenteropancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Carcinoid and neuroendocrine tumors of the colon and rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Gastrointestinal carcinoids: characterization by site of origin and hormone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Endocrine tumours of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Gastrinoma (duodenal and pancreatic).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Chromosomal alterations detected by comparative genomic hybridization in nonfunctioning endocrine pancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

The diagnosis and medical management of advanced neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Current status of gastrointestinal carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

OctreoScan positive Crohn's disease mimicking an ileal carcinoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Ablative therapies for liver metastases of digestive endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Clinical presentation and management of carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Peptide-receptor radionuclide therapy for endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Histidine decarboxylase expression in pancreatic endocrine cells and related tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0794-7

Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival

21 January 2018

1 reference

12 December 2020

Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors

1 reference

12 December 2020

Nonfunctioning islet cell tumors

1 reference

12 December 2020

Pancreatic islet cell carcinoma. I. Clinical features of 52 patients

1 reference

12 December 2020

Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.

1 reference

12 December 2020

Surgery increases survival in patients with gastrinoma

1 reference

12 December 2020

Circulating Ghrelin Levels in Patients with Pancreatic and Gastrointestinal Neuroendocrine Tumors: Identification of One Pancreatic Ghrelinoma

1 reference

12 December 2020

A comparison between three commercial kits for chromogranin A measurements

1 reference

12 December 2020

High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.

1 reference

12 December 2020

Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours

1 reference

12 December 2020

Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase

1 reference

12 December 2020

Genomic imbalances in the progression of endocrine pancreatic tumors

1 reference

12 December 2020

EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience

1 reference

12 December 2020

Midgut carcinoid tumors: CT findings and biochemical profiles

1 reference

12 December 2020

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

1 reference

12 December 2020

Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours

1 reference

12 December 2020

Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms

1 reference

12 December 2020

Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center

1 reference

12 December 2020

Pharmacotherapy of neuroendocrine cancers

1 reference

12 December 2020

Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma

1 reference

12 December 2020

Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors

1 reference

12 December 2020

The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer

1 reference

12 December 2020

Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity

1 reference

12 December 2020

Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience

1 reference

12 December 2020

Synaptophysin. A new marker for pancreatic neuroendocrine tumors

1 reference

12 December 2020

Current concepts in the diagnosis and management of small-cell lung cancer.

1 reference

12 December 2020

Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations

1 reference

12 December 2020

10.1007/S00423-011-0794-7

Identifiers

DOI

1 reference

24 August 2017

1 reference